These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16029915)

  • 1. Multi-antigen immunization using IgG binding domain ZZ as carrier.
    Zhao Y; Benita Y; Lok M; Kuipers B; van der Ley P; Jiskoot W; Hennink WE; Crommelin DJ; Oosting RS
    Vaccine; 2005 Oct; 23(43):5082-90. PubMed ID: 16029915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing immunogenicity of antigens fused to Ig-binding proteins by cell surface targeting.
    Léonetti M; Thai R; Cotton J; Leroy S; Drevet P; Ducancel F; Boulain JC; Ménez A
    J Immunol; 1998 Apr; 160(8):3820-7. PubMed ID: 9558086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An hsp70 fusion protein vaccine potentiates the immune response against Japanese encephalitis virus.
    Ge FF; Qiu YF; Yang YW; Chen PY
    Arch Virol; 2007 Jan; 152(1):125-35. PubMed ID: 16862385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion of antigen to chemokine CCL20 or CXCL13 strategy to enhance DNA vaccine potency.
    Guo JH; Fan MW; Sun JH; Jia R
    Int Immunopharmacol; 2009 Jul; 9(7-8):925-30. PubMed ID: 19348967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria.
    van Roosmalen ML; Kanninga R; El Khattabi M; Neef J; Audouy S; Bosma T; Kuipers A; Post E; Steen A; Kok J; Buist G; Kuipers OP; Robillard G; Leenhouts K
    Methods; 2006 Feb; 38(2):144-9. PubMed ID: 16414272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
    Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
    Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity.
    Huleatt JW; Jacobs AR; Tang J; Desai P; Kopp EB; Huang Y; Song L; Nakaar V; Powell TJ
    Vaccine; 2007 Jan; 25(4):763-75. PubMed ID: 16968658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
    Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS
    Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of a recombinant Mycobacterium bovis bacille Calmette-Guèrin expressing malarial and tuberculosis epitopes.
    Rapeah S; Norazmi MN
    Vaccine; 2006 Apr; 24(17):3646-53. PubMed ID: 16494975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
    Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
    Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentabody-mediated antigen delivery induces antigen-specific mucosal immune response.
    Li S; Zheng W; Kuolee R; Hirama T; Henry M; Makvandi-Nejad S; Fjällman T; Chen W; Zhang J
    Mol Immunol; 2009 May; 46(8-9):1718-26. PubMed ID: 19269688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunogenicity of an antigen-polyelectrolyte complex mixture is higher than that of a general complex carrying a number of antigen molecules.
    Petrov RV; Mustafaev MI; Norimov ASh
    Biomed Sci; 1990; 1(5):531-3. PubMed ID: 1723006
    [No Abstract]   [Full Text] [Related]  

  • 14. The FAI protein of group C streptococci targets B-cells and exhibits adjuvant activity.
    Schulze K; Goldmann O; Toppel A; Medina E; Guzmán CA
    Vaccine; 2005 Feb; 23(11):1408-13. PubMed ID: 15661390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
    Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
    Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis.
    Fujiwara RT; Vale AM; França da Silva JC; da Costa RT; Quetz Jda S; Martins Filho OA; Reis AB; Corrêa Oliveira R; Machado-Coelho GL; Bueno LL; Bethony JM; Frank G; Nascimento E; Genaro O; Mayrink W; Reed S; Campos-Neto A
    Vet Res; 2005; 36(5-6):827-38. PubMed ID: 16120256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan microspheres enhance the immunogenicity of an Ag85B-based fusion protein containing multiple T-cell epitopes of Mycobacterium tuberculosis.
    Zhu Bd; Qie Yq; Wang Jl; Zhang Y; Wang Qz; Xu Y; Wang Hh
    Eur J Pharm Biopharm; 2007 Jun; 66(3):318-26. PubMed ID: 17280823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope.
    Lu Y; Ouyang K; Fang J; Zhang H; Wu G; Ma Y; Zhang Y; Hu X; Jin L; Cao R; Fan H; Li T; Liu J
    Vaccine; 2009 Aug; 27(39):5411-8. PubMed ID: 19616501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modifications increasing the efficacy of recombinant vaccines; marked increase in antibody titers with moderately repetitive variants of a therapeutic allergy vaccine.
    Johansson J; Hellman L
    Vaccine; 2007 Feb; 25(9):1676-82. PubMed ID: 17150285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotype-specificity of recombinant fusion proteins containing domain III of dengue virus.
    Izquierdo A; Bernardo L; Martin J; Santana E; Hermida L; Guillén G; Guzmán MG
    Virus Res; 2008 Dec; 138(1-2):135-8. PubMed ID: 18796319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.